桂枝茯苓胶囊联合腹腔镜手术治疗子宫内膜异位症的效果及安全性

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (583 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the efficacy and safety of Guizhi Fuling Capsules combined with laparoscopic surgery in the treatment of endometriosis. Methods A total of 90 patients with endometriosis admitted to Weihai Second Hospital Affiliated to Qingdao University from January 2020 to January 2022 were selected as research objects, they were divided into observation group and control group according to random number table method, with 45 cases in each group. The observation group was treated with Guizhi Fuling Capsules combined with laparoscopic surgery, and the control group was treated with laparoscopic surgery alone. The effects, adverse reactions, sex hormones, inflammatory factors, T lymphocytes, visual analogue scale (VAS) and endometriosis health scale (EHP-30) were compared between the two groups. Results The total effective rate of observation group was higher than that of control group, the difference was statistically significant (P＜0.05). There were no significant differences in gastrointestinal symptoms, liver and kidney function injury, bleeding and wound pain complications between two groups (P＞0.05). After treatment, estradiol (E2), luteinizing hormone (LH) and progesterone (P) in observation group were lower than those in control group, and the differences were statistically significant (P＜0.05). After treatment, interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), CD3+, CD4+ and CD8+ in observation group were lower than those in control group, and the differences were statistically significant (P＜0.05). VAS and EHP-30 score of observation group were lower than those of control group after treatment, and the differences were statistically significant (P＜0.05). Conclusion Guizhi Fuling Capsules combined with laparoscopic surgery can improve the sex hormone, inflammatory response and T lymphocyte immunity in patients with endometriosis, and has the advantages of high efficiency and safety, its efficacy is higher than that of laparoscopic surgery, and it is worthy of widespread promotion in clinical practice.

Key words： Endometriosis Guizhi Fuling Capsules Laparoscopic surgery Efficacy Security

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	REN Xiulan YANG Xinhong

Cite this article:

REN Xiulan YANG Xinhong. Efficacy and safety of Guizhi Fuling Capsules combined with laparoscopic surgery in the treatment of endometriosis[J]. 中国当代医药, 2024, 31(1): 72-75.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2024/V31/I1/72

[1]	Bafort C，Beebeejaun Y，Tomassetti C，et al.Laparoscopic surgery for endometriosis[J].Cochrane Database Syst Rev，2020，10（10）：CD011031.
[2]	Restaino S，Mereu L，Finelli A，et al.Robotic surgery vs laparoscopic surgery in patients with diagnosis of endometriosis：a systematic review and meta-analysis[J].J Robot Surg，2020，14（5）：687-694.
[3]	Ono Y，Furumura K，Yoshino O，et al.Influence of laparoscopic surgery for endometriosis and its recurrence on perinatal outcomes[J].Reprod Med Biol，2022，21（1）：e12456.
[4]	Ceccaroni M，Clarizia R，Liverani S，et al.Dienogest vs GnRH agonists as postoperative therapy after laparoscopic eradication of deep infiltrating endometriosis with bowel and parametrial surgery：a randomized controlled trial[J].Gynecol Endocrinol，2021，37（10）：930-933.
[5]	王温馨，王树瑜，赵烨.地诺孕素治疗子宫内膜异位症的安全性研究进展[J].实用药物与临床，2023，26（2）：167-171.
[6]	于晓川，朱芳，吴丹丹.子宫内膜异位症术后戈舍瑞林联合桂枝茯苓胶囊治疗效果及对患者炎症因子水平影响[J].中国计划生育学杂志，2022，30（3）：625-629.
[7]	石吟，阮凡，郑颖.桂枝茯苓胶囊改善轻度子宫内膜异位症性不孕患者术后妊娠结局的安全性与有效性[J].中国临床药理学与治疗学，2018，23（12）：1392-1396.
[8]	中国中西医结合学会妇产科专业委员会.子宫内膜异位症中西医结合诊治指南[J].中国中西医结合杂志，2019， 39（10）：1169-1176.
[9]	张玉侠，刘萍，郭爱玲，等.卵巢型子宫内膜异位症腹腔镜术后地屈孕酮辅助治疗效果及对血清HE4、AMH影响[J].中国计划生育学杂志，2022，30（6）：1286-1289.
[10]	方丽丽.中医护理在肛周脓肿手术中的应用效果和VAS评分评价[J].中外医疗，2022，41（31）：171-175.
[11]	李娜，张永.桂枝茯苓胶囊治疗子宫内膜异位症及对患者血清Flk-1、COX-2、VEGF、PGE2水平的影响[J].中国计划生育学杂志，2022，30（9）：1977-1982.
[12]	许姣姣，周子钧，孙丽燕，等.子宫内膜异位症与炎症的相关研究进展[J].中国妇幼保健，2022，37（24）：4767-4770.
[13]	林丽娜，丛慧芳.免疫细胞参与子宫内膜异位症发病机制的研究进展[J].河北医学，2022，28（7）：1223-1226.
[14]	来庆玲，汤小晗，卢美松.免疫细胞在子宫内膜异位症发病机制中的作用研究新进展[J].中国计划生育和妇产科，2022，14（9）：41-43.
[15]	陈金娇.子宫内膜异位症原位内膜免疫细胞浸润特征的分析与验证[D]广州：广州医科大学，2022.
[16]	林锦璇，吴金香，邱月娜，等.桂枝茯苓丸治疗子宫内膜异位症研究进展[J].中成药，2023，45（1）：166-169.
[17]	姚莉，吕艳春，蔡婉明，等.桂枝茯苓丸联合地诺孕素治疗子宫内膜异位症的临床研究[J].现代药物与临床，2022，37（11）：2588-2592.
[18]	赵曰明，刘芳芳，孙海波.桂枝茯苓联合GnRH-a治疗子宫内膜异位症腹腔镜术后痛经效果[J].中国计划生育学杂志，2022，30（5）：1018-1021.
[19]	胡婷婷，程静，董利平.加味桂枝茯苓汤联合GnRHa治疗子宫内膜异位症的疗效及对患者性激素及体液免疫功能的影响[J].海南医学，2022，33（8）：1016-1019.
[20]	金芬，周英惠，张吉，等.基于网络药理学探讨桂枝茯苓丸治疗子宫内膜异位症的作用机制[J].河南中医，2021，41（8）：1251-1255.